Cargando…

Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats

BACKGROUND: Emerging evidence suggests beneficial effects of omega-3 fatty acids on diabetic complications. The present study compared the progressive effects of metformin and flax/fish oil on lipid metabolism, inflammatory markers, and liver and renal function test markers in streptozotocin-nicotin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghadge, Abhijit, Harsulkar, Abhay, Karandikar, Manjiri, Pandit, Vijaya, Kuvalekar, Aniket
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968436/
https://www.ncbi.nlm.nih.gov/pubmed/27551311
http://dx.doi.org/10.1186/s12263-016-0518-4
_version_ 1782445658856226816
author Ghadge, Abhijit
Harsulkar, Abhay
Karandikar, Manjiri
Pandit, Vijaya
Kuvalekar, Aniket
author_facet Ghadge, Abhijit
Harsulkar, Abhay
Karandikar, Manjiri
Pandit, Vijaya
Kuvalekar, Aniket
author_sort Ghadge, Abhijit
collection PubMed
description BACKGROUND: Emerging evidence suggests beneficial effects of omega-3 fatty acids on diabetic complications. The present study compared the progressive effects of metformin and flax/fish oil on lipid metabolism, inflammatory markers, and liver and renal function test markers in streptozotocin-nicotinamide-induced diabetic rats. METHODS: Streptozotocin-induced diabetic rats were randomized into control and four diabetic groups: streptozotocin (STZ), metformin (200 mg/kg body weight (b.w)/day (D)), flax and fish oil (500 mg/kg b.w/D). RESULTS: Metformin and flax and fish oil exhibited increased expression of transcription factor peroxisome proliferator-activated receptor γ while the treatment downregulated sterol regulatory element-binding protein 1 and nuclear factor kβ as compared to those of the STZ group. Apart from modulation of transcription factor expression, the expression of fatty acid synthase, long chain acyl CoA synthase, and malonyl-CoA-acyl carrier protein transacylase was lowered by flax/fish oil treatment. Serum cholesterol, triglycerides, and VLDL were also significantly reduced in the treatment groups as compared to those in the STZ group. Although pathological abnormalities were seen in the liver and kidneys of rats on metformin, no significant changes in liver/renal function markers were observed at day 15 and day 30 of the treatment groups. Flax/fish oil had protective effects toward pathological abnormalities in the liver and kidney. Flax/fish oil improved lipid profile and alkaline phosphatase at day 30 as compared to that at day 15. CONCLUSIONS: The present study demonstrates potential beneficial effects of metformin and flax/fish oil intervention in improving serum lipid profile by regulating the expression of transcription factors and genes involved in lipid metabolism in diabetic rats. In addition, these interventions also lowered the expression of atherogenic cytokines. The protective effects of flax/fish oil are worth investigating in human subjects on metformin monotherapy.
format Online
Article
Text
id pubmed-4968436
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49684362016-08-22 Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats Ghadge, Abhijit Harsulkar, Abhay Karandikar, Manjiri Pandit, Vijaya Kuvalekar, Aniket Genes Nutr Research Paper BACKGROUND: Emerging evidence suggests beneficial effects of omega-3 fatty acids on diabetic complications. The present study compared the progressive effects of metformin and flax/fish oil on lipid metabolism, inflammatory markers, and liver and renal function test markers in streptozotocin-nicotinamide-induced diabetic rats. METHODS: Streptozotocin-induced diabetic rats were randomized into control and four diabetic groups: streptozotocin (STZ), metformin (200 mg/kg body weight (b.w)/day (D)), flax and fish oil (500 mg/kg b.w/D). RESULTS: Metformin and flax and fish oil exhibited increased expression of transcription factor peroxisome proliferator-activated receptor γ while the treatment downregulated sterol regulatory element-binding protein 1 and nuclear factor kβ as compared to those of the STZ group. Apart from modulation of transcription factor expression, the expression of fatty acid synthase, long chain acyl CoA synthase, and malonyl-CoA-acyl carrier protein transacylase was lowered by flax/fish oil treatment. Serum cholesterol, triglycerides, and VLDL were also significantly reduced in the treatment groups as compared to those in the STZ group. Although pathological abnormalities were seen in the liver and kidneys of rats on metformin, no significant changes in liver/renal function markers were observed at day 15 and day 30 of the treatment groups. Flax/fish oil had protective effects toward pathological abnormalities in the liver and kidney. Flax/fish oil improved lipid profile and alkaline phosphatase at day 30 as compared to that at day 15. CONCLUSIONS: The present study demonstrates potential beneficial effects of metformin and flax/fish oil intervention in improving serum lipid profile by regulating the expression of transcription factors and genes involved in lipid metabolism in diabetic rats. In addition, these interventions also lowered the expression of atherogenic cytokines. The protective effects of flax/fish oil are worth investigating in human subjects on metformin monotherapy. BioMed Central 2016-03-17 /pmc/articles/PMC4968436/ /pubmed/27551311 http://dx.doi.org/10.1186/s12263-016-0518-4 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Paper
Ghadge, Abhijit
Harsulkar, Abhay
Karandikar, Manjiri
Pandit, Vijaya
Kuvalekar, Aniket
Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats
title Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats
title_full Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats
title_fullStr Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats
title_full_unstemmed Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats
title_short Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats
title_sort comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968436/
https://www.ncbi.nlm.nih.gov/pubmed/27551311
http://dx.doi.org/10.1186/s12263-016-0518-4
work_keys_str_mv AT ghadgeabhijit comparativeantiinflammatoryandlipidnormalizingeffectsofmetforminandomega3fattyacidsthroughmodulationoftranscriptionfactorsindiabeticrats
AT harsulkarabhay comparativeantiinflammatoryandlipidnormalizingeffectsofmetforminandomega3fattyacidsthroughmodulationoftranscriptionfactorsindiabeticrats
AT karandikarmanjiri comparativeantiinflammatoryandlipidnormalizingeffectsofmetforminandomega3fattyacidsthroughmodulationoftranscriptionfactorsindiabeticrats
AT panditvijaya comparativeantiinflammatoryandlipidnormalizingeffectsofmetforminandomega3fattyacidsthroughmodulationoftranscriptionfactorsindiabeticrats
AT kuvalekaraniket comparativeantiinflammatoryandlipidnormalizingeffectsofmetforminandomega3fattyacidsthroughmodulationoftranscriptionfactorsindiabeticrats